Clinician's guide to human papillomavirus immunology: knowns and unknowns.
about
Role of human papillomaviruses in carcinogenesisHPV vaccine: Current status and future directionsEpidemiology and genotype distribution of human papillomavirus (HPV) in Southwest China: a cross-sectional five years study in non-vaccinated women.Evaluation of 'see-see and treat' strategy and role of HIV on cervical cancer prevention in Uganda.Perspectives for preventive and therapeutic HPV vaccines.Identification of protein biomarkers for cervical cancer using human cervicovaginal fluidAccuracy of urinary human papillomavirus testing for presence of cervical HPV: systematic review and meta-analysisHPV vaccine: an overview of immune response, clinical protection, and new approaches for the future.HPV clearance in postpartum period of HIV-positive and negative women: a prospective follow-up study.Clearance of persistent HPV infection and cervical lesion by therapeutic DNA vaccine in CIN3 patients.Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Changes in antibody seroprevalence of seven high-risk HPV types between nationwide surveillance studies from 1995-96 and 2006-07 in The Netherlands.HPV16 seropositivity and subsequent HPV16 infection risk in a naturally infected population: comparison of serological assays.Long-term persistence of prevalently detected human papillomavirus infections in the absence of detectable cervical precancer and cancer.Proliferation inhibition and apoptosis enhancement of human cervical cancer cells by ultrasound-targeted microbubble destruction delivered double suicide genes.Tumor necrosis factor blockade and the risk of viral infectionThe role of sexual behavior in head and neck cancer: implications for prevention and therapy.A comparative study of two different assay kits for the detection of secreted alkaline phosphatase in HPV antibody neutralization assays.Association of HPV types 6, 11, 16, and 18 DNA detection and serological response in unvaccinated adolescent women.Cervical cytokines and clearance of incident human papillomavirus infection: Hawaii HPV cohort studyPrevalence of high-risk human papilloma virus among women with hepatitis C virus before liver transplantation.The relation of plasmacytoid dendritic cells (pDCs) and regulatory T-cells (Tregs) with HPV persistence in HIV-infected and HIV-uninfected women.Cervical Cancer: Development of Targeted Therapies Beyond Molecular Pathogenesis.Transplacental Transmission of Human Papillomavirus.HPV vaccine: Cervarix.Inductive/effector mechanisms for humoral immunity at mucosal sites.Ubiquitination in host immune response to human papillomavirus infection.Detection of human papillomavirus DNA in urine. A review of the literature.Nutrition support and therapy in patients with head and neck squamous cell carcinomas.Human papillomavirus and oropharyngeal squamous cell carcinoma: what the clinician should know.Toll-like receptors in human papillomavirus infection.Involvement of autophagy in cervical, endometrial and ovarian cancer.E3 ubiquitin ligases and human papillomavirus-induced carcinogenesis.Functional effects of sequence variations in the E6 and E2 genes of human papillomavirus 16 European and Asian variants.Molecular genetic characterization of p53 mutated oropharyngeal squamous cell carcinoma cells transformed with human papillomavirus E6 and E7 oncogenesGender and age-specific seroprevalence of human papillomavirus 16 and 18 in general population in Tehran, Iran.Current and Emerging Molecular Tests for Human Papillomavirus-Related Neoplasia in the Genomic Era.Transmission between Archaic and Modern Human Ancestors during the Evolution of the Oncogenic Human Papillomavirus 16.Immunopathogenesis of HPV-Associated Cancers and Prospects for Immunotherapy.[Anogenital diseases caused by human papillomavirus - A modern pandemia].
P2860
Q22305628-972BA18A-CC26-4E40-B04C-3E7A7A220A1BQ27026524-EE046569-1B66-4B5A-A915-A5F65E3C8963Q33592432-245ED40B-D088-4DB7-A17D-D8A744331EB1Q33900433-2CD64AA2-2420-4EB7-9487-F8AB2D1B445CQ34011494-7F4C2A33-5E53-4B33-9D17-D4F411E9EC21Q34172304-81EC8975-F626-4526-A9D4-EAE45B1A9715Q34197975-0B6986E0-2302-4F85-B0C3-B896D2919236Q34335370-1C0AD965-2C60-4611-B1D6-FE30313411EEQ34448633-CB914DF5-9385-4D8E-8034-21939290A636Q34453827-D4696FBB-0FEE-4F85-9C00-979CC87A04CEQ34467932-BFFF8FA1-5286-4309-BFDE-4427D29C6AE1Q34477498-F153BC6E-D482-4737-808B-CAED5588C006Q34542304-017F8FE8-7074-4E3D-87EF-0828C342DC76Q34763988-18DF38EF-792E-4737-85CB-057498FB7D2CQ35017160-2D903414-D0FC-4C60-9F39-4F405BD3A5C5Q35161630-0EDB46EE-A303-42BB-B53B-175350D43C78Q35272050-F56E77C0-71D9-4082-B75D-D31CF55CF7E9Q35887709-A623BCF2-2F40-43A6-8571-BE39AD503AE3Q36921606-30502E96-C992-49CC-9BD3-2D18A2678AE9Q37067273-22C90948-B42D-4673-88C6-86702E80CD69Q37178173-86FD07B3-DF2E-45B2-87E8-193E11A780C5Q37577065-E16A39FD-295E-421D-B5B0-3B16B4D5EB59Q37579334-9494DB6C-1740-47A7-837E-C68AED0A78EDQ37668936-5EBE00AB-8487-4421-A223-399E1ADC794DQ37687426-DDEE1D30-EB28-4473-823D-E2EE6F9F3ABDQ37827572-ECC0ED1D-8812-43EC-A3A0-32DA4321C82FQ37852608-87DBDBE6-32CF-4B7B-9B58-AB3BE1B209F4Q37912034-2963AD28-7CE4-462C-BBEE-56C8FB59CC90Q38022454-A12590F7-A3BF-4428-BF66-59A60092201CQ38023262-C7A40D3F-D65F-414C-B45C-C150801231C6Q38084160-3BBF5B16-74B7-4594-8D3D-7EBB21361730Q38152325-7BEBD557-B502-47A9-B511-7306869DFA6DQ38180349-B1FC7CB2-11C9-4CD3-87CC-B7BD6794F4D7Q39073259-451EA8AC-82C3-42A6-A16C-2E74C5335508Q39147256-ED28E525-FEAF-4617-B782-A5BBFB297E77Q39178605-43F2DA0F-7792-404F-8DA5-A29C697C78F6Q39191687-ED81AB65-CFE5-46E6-B574-5F6E119F49F1Q39356598-D869FBF1-652A-4AC0-84CF-8D78E585A1DDQ40045752-D838153E-AD17-46B8-824A-71FE1FE002D1Q40754641-03AD0C98-CD9B-491F-94A4-72195BF1EF4C
P2860
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@ast
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@en
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@nl
type
label
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@ast
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@en
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@nl
prefLabel
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@ast
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@en
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@nl
P2093
P1476
Clinician's guide to human papillomavirus immunology: knowns and unknowns.
@en
P2093
David Jenkins
Howard D Strickler
John T Schiller
Mark H Einstein
Neal Halsey
Pierre Coursaget
Raphael P Viscidi
P304
P356
10.1016/S1473-3099(09)70108-2
P50
P577
2009-06-01T00:00:00Z